Flosonics

Based in Sudbury, Ontario, Canada, Flosonics Medical develops FloPatch, a wireless, wearable Doppler ultrasound sensor designed for real-time hemodynamic monitoring in critical care environments. The medical technology company provides hospitals and emergency medicine clinicians with a hands-free device to precisely manage fluid resuscitation for patients experiencing shock, sepsis, or severe trauma. Operating with a workforce of 93 employees, the enterprise has generated $23.3 million in revenue while securing $44.2 million in total funding to support its ongoing commercialization and manufacturing efforts. Flosonics has received financial backing from institutions including RBCx, graduated from the Fogarty Innovation program, and appointed industry figures such as Dan Kidle, Mary Jo Gorman, and Sam Ifergan to its board of directors. The medical device organization was founded in 2015 by co-founders Joseph Eibl, Jon-Emile Kenny, and Andrew Eibl.